miR‐655 suppresses epithelial‐to‐mesenchymal transition by targeting Prrx1 in triple‐negative breast cancer

Triple‐negative breast cancer (TNBC) is a highly aggressive breast cancer subtype that lacks effective targeted therapies. The epithelial‐to‐mesenchymal transition (EMT) is a key contributor in the metastatic process. In this study, we found that miR‐655 was down‐regulated in TNBC, and its expressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Zhi‐Dong, Kong, Bin, Liu, Xiang‐Ping, Jin, Li‐Ying, Dong, Qian, Li, Fu‐Nian, Wang, Hai‐Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831358/
https://www.ncbi.nlm.nih.gov/pubmed/26820102
http://dx.doi.org/10.1111/jcmm.12770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831358/
https://www.ncbi.nlm.nih.gov/pubmed/26820102
http://dx.doi.org/10.1111/jcmm.12770

Ejemplares similares